Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies is a research paper published in Brain Communications (2020). On theSindex it has a DataRank of 0. It has been cited 49 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke National Institutes of Health
Grant: U54-NS110435
National Institute of Neurological Disorders and Stroke National Institutes of Health
Grant: R21-NS107950
Parkinson’s Disease Foundation Stanley Fahn Award
Grant: PF-JFA-1884
National Institutes of Health
Grant: R01-NS083845
National Institutes of Health
Grant: P50-AG005134
NINDS NIH HHS
Grant: R01 NS083845
Medical Research Council
Grant: UKDRI-2003
Medical Research Council
Grant: UKDRI-1012
European Research Council
Grant: 669237
Characterising protein oligomers and their role in neurodegenerative disease in humans
NINDS NIH HHS
Grant: RF1 NS083845
NIA NIH HHS
Grant: P30 AG062421
NINDS NIH HHS
Grant: U54 NS110435
NIA NIH HHS
Grant: P50 AG005134
NINDS NIH HHS
Grant: R21 NS104576
National Institutes of Health
Grant: 5U54NS110435-02
Synergistic Interaction of amyloid-beta and alpha-synuclein in Lewy body Dementia
National Institutes of Health
Grant: 5U2GPS002014-03
TECHNICAL ASSISTANCE TO THE NATIONAL BLOOD TRANSFUSION CENTER [MINISTRY OF HEALTH
National Institutes of Health
Grant: 3P50AG005134-04S3
ALZHEIMERS DISEASE RESEARCH CENTER
National Institutes of Health
Grant: 5R01NS083845-05
Biology of Native Alpha-Synuclein Tetramers in Parkinson's Disease
American Parkinson Disease Association Research
UK Dementia Research Institute
Michael J. Fox Foundation LEAPS
Royal Society and European Research Council
FWCI
3.18
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies
Additional file 1 of Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies
Additional file 7 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 3 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 8 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 8 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 5 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 7 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 3 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 1 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 5 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 4 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 6 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 6 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 1 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 2 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 2 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro
Additional file 4 of Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro